Page last updated: 2024-11-04

tegafur and Anemia, Macrocytic

tegafur has been researched along with Anemia, Macrocytic in 1 studies

Anemia, Macrocytic: Anemia characterized by larger than normal erythrocytes, increased mean corpuscular volume (MCV) and increased mean corpuscular hemoglobin (MCH).

Research Excerpts

ExcerptRelevanceReference
"One hundred and thirty-seven cases of stomach cancer given fluoropyrimidines (UFT: 66 cases, Tegafur: 58 cases, 5-FU: 13 cases) after gastrectomy as the adjuvant chemotherapy were examined as to appearance of macrocytic anemia."1.28[Macrocytic anemia as a possible adverse effect of fluoropyrimidines]. ( Arai, K; Awane, Y; Kitamura, M; Miyashita, K, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, K1
Awane, Y1
Kitamura, M1
Miyashita, K1

Other Studies

1 other study available for tegafur and Anemia, Macrocytic

ArticleYear
[Macrocytic anemia as a possible adverse effect of fluoropyrimidines].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:8 Pt 1

    Topics: Anemia, Macrocytic; Antineoplastic Combined Chemotherapy Protocols; Erythrocyte Indices; Female; Flu

1990